Fatal outcome of a hypersensitivity reaction to paclitaxel: a case report

Jan P. van Meerbeeck; Jeroen S. Kloover; Michael A. den Bakker

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

8/2002
vol. 6

Send email

Copy url:

abstract:

Fatal outcome of a hypersensitivity reaction to paclitaxel: a case report

Jan P. van Meerbeeck

,

Jeroen S. Kloover

,

Michael A. den Bakker

Współ Onkol (2002), vol. 6, 8, 486-489

Online publish date: 2003/04/11

View full text Get citation

Hypersensitivity reactions (HSRs) to paclitaxel are frequently encountered in patients receiving this anti-tumor drug. Oral pre-medication with dexamethasone at a dose of 20 mg and given orally at 12 and 6 hours before infusion of paclitaxel have been shown to reduce the incidence of paclitaxel-induced HSRs significantly. However, due to logistic factors, short-course pre-medication with intravenously administered dexamethasone given 30 minutes prior to paclitaxel infusion became customary and retrospective analysis showed that this pre-medication schedule was as effective as the oral regimen. In this case report we describe the fatal outcome of a HSR in a patient receiving paclitaxel despite short-course pre-medication. The level of evidence supporting the short-course iv pre-medication schedule is challenged, as it is not compatible with the pharmacokinetic properties of dexamethasone.

keywords:

Fatal outcome of a hypersensitivity reaction to paclitaxel: a case report

Jan P. van Meerbeeck , Jeroen S. Kloover , Michael A. den Bakker

hypersensitivity reaction, paclitaxel, anaphylaxis, dexamethasone, premedication, chemotherapy

Jan P. van Meerbeeck

,

Jeroen S. Kloover

,

Michael A. den Bakker